Tenon Medical, Inc. 8-K

What Happened
Tenon Medical, Inc. announced its financial results for the quarter ended March 31, 2026 in a press release dated May 12, 2026 and furnished the release as Exhibit 99.1 to an 8‑K (Item 2.02). The company scheduled a conference call for May 12, 2026 at 4:30 p.m. ET (1:30 p.m. PT) to discuss the results, give a corporate update, and conduct Q&A with its covering analyst. An audio playback of the call will be available through May 26, 2026 on the company’s Investor Relations website or by telephone replay (US: 1‑844‑512‑2921; International: 1‑412‑317‑6671) using access code 13759830. The filing notes the press release and related information are being furnished and are not “filed” for purposes of Section 18 of the Exchange Act.

Key Details

• Press release announcing Q1 2026 results furnished as Exhibit 99.1 (filed May 12, 2026).
• Quarter covered: three months ended March 31, 2026.
• Conference call: May 12, 2026 at 4:30 p.m. ET (1:30 p.m. PT); replay available through May 26, 2026 (access code 13759830).
• Filing classification: Item 2.02 (Results of Operations and Financial Condition); Exhibit noted under Item 9.01(d).

Why It Matters
This 8‑K signals Tenon Medical is releasing its quarterly earnings and management commentary—important for investors tracking revenue, profitability, and any updates to business outlook. The conference call and replay give investors direct access to management discussion and analyst Q&A. Because the 8‑K furnishes the press release (rather than “files” it under Section 18), investors should review the press release and listen to the call or replay for the specific financial figures and any forward‑looking commentary.